Drug Shortage Report for TRISPAN
Report ID | 197812 |
Drug Identification Number | 02470632 |
Brand name | TRISPAN |
Common or Proper name | TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSION |
Company Name | MEDEXUS PHARMACEUTICALS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TRIAMCINOLONE HEXACETONIDE |
Strength(s) | 20MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRASYNOVIAL PERIARTICULAR INTRA-ARTICULAR PERIARTICULAR INTRASYNOVIAL INTRA-ARTICULAR |
Packaging size | 1 ml ampoule - 10 ampoules/pack |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-09-01 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | Drug is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 35 NIXON ROAD, UNIT 10 BOLTON, ONTARIO CANADA L7E 1K1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-04-16 | English | Compare |
v6 | 2024-03-18 | French | Compare |
v5 | 2024-03-18 | English | Compare |
v4 | 2023-09-02 | English | Compare |
v3 | 2023-08-03 | English | Compare |
v2 | 2023-07-07 | French | Compare |
v1 | 2023-07-07 | English | Compare |
Showing 1 to 7 of 7